GlaxoSmithKline (GSK) has entered into an agreement to acquire Boston-based IDRx for up to $1.15 billion, securing rights to IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST). The deal comprises an upfront payment of $1 billion and a potential $150 million regulatory milestone payment.
Bio-Rad Laboratories has enhanced its downstream bioprocessing capabilities with larger-diameter prepacked chromatography columns. The expansion builds upon their existing Foresight Pro range, offering increased scalability options for the purification of biotherapeutics including monoclonal antibodies, recombinant proteins, and vaccines.
International medical technology company Mindray has introduced new platelet counting technology to European markets, incorporating artificial intelligence and multiple detection methods to enhance accuracy in clinical haematology laboratories. The CAL 8000 Cellular Analysis Line aims to reduce pseudothrombocytopenia and pseudothrombocytosis errors in diagnostic testing.
A programmable five-position stirring hot plate offering precise temperature control and multiple stirring positions has been launched by Torrey Pines Scientific. The EchoTherm Model HS65 aims to enhance laboratory workflow efficiency in chemical, pharmaceutical, environmental and biochemical applications where reproducible sample preparation is essential.
Cambridge-based Panakeia has announced PANProfiler Colon, an artificial intelligence-driven software tool that determines micro-satellite instability (MSI) and mismatch repair deficiency (dMMR) status from H&E-stained tissue samples within minutes. The technology aims to accelerate molecular profiling for precision medicine in colorectal cancer treatment.
German CDMO ProBioGen has announced significant expansion of its biomanufacturing capabilities through commissioning of an additional 1000L GMP production line for protein therapeutics and completion of a new viral vector manufacturing unit at its Berlin facilities.
Bio-Rad Laboratories has introduced a new mixed-mode chromatography resin designed for biomolecule purification across multiple scales. The Nuvia wPrime 2A Media combines weak anion exchange with hydrophobic interaction chromatography, offering potential advantages for both research and industrial-scale therapeutic protein production
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Touchlight’s Hampton facility a Manufacturer’s Authorisation for Investigational Medicinal Products (MIA, IMP) licence, marking a significant advancement in synthetic DNA production. This certification enables the manufacture of Investigational Active Pharmaceutical Ingredients (API) and critical starting materials for Advanced Therapy Medicinal Products (ATMP).
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific have announced a strategic partnership to optimise T cell expansion protocols, combining Terumo BCT’s Quantum Flex Cell Expansion System with FUJIFILM’s PRIME-XV T Cell Expansion Media. This collaboration addresses significant manufacturing challenges faced by cell therapy developers, particularly those in early-stage development.
Monheim-based Cube Biotech has acquired IBA Lifesciences in a strategic transaction that combines two significant players in protein research and production technologies. The acquisition, announced on 13 January 2025, creates an entity with enhanced capabilities in membrane protein production, purification, and stabilisation technologies.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
